Matthew Dpm Smith
Podiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Matthew Dpm Smith’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$159,494
Medicare paid this office $159,494 for 1,503 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 253 | $49,706 | $83 |
| Insertion of needle into vein for collection of blood sample | 1,303 | $26,979 | $9 |
| Removal of fingernails or toenails, 6 or more nails | 179 | $15,000 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 68 | $11,800 | $82 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $11,070 | $132 |
See all 15 services
| Short return visit (20+ min) | 253 | $49,706 | $83 |
| Insertion of needle into vein for collection of blood sample | 1,303 | $26,979 | $9 |
| Removal of fingernails or toenails, 6 or more nails | 179 | $15,000 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 68 | $11,800 | $82 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $11,070 | $132 |
| New patient visit (30+ min) | 96 | $9,495 | $99 |
| Return visit (30+ min) | 40 | $7,606 | $121 |
| New patient visit (45+ min) | 41 | $6,066 | $148 |
| Removal of noncancer thickened skin growth, 1 growth | 47 | $4,282 | $65 |
| Strapping, unna boot | 15 | $3,165 | $58 |
| Short return visit | 45 | $3,139 | $56 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 81 | $1,634 | $15 |
| Influenza vaccine split virus, preservative free | 17 | $1,391 | $82 |
| Removal of fingernails or toenails, 1-5 nails | 21 | $718 | $30 |
| Administration of influenza virus vaccine | 18 | $703 | $39 |
Procedures Medicare counted
| Removal of nail tissue | 347 | More than 80% of doctors who do this |
| Removal of skin lesions | 26 | More than 67% of doctors who do this |
| Removal of tissue | 59 | More than 80% of doctors who do this |
| Removal or shaving of skin growth | 191 | More than 89% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
1,503 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 17% · Women 60% · Also on Medicaid 10% · Health risk score 1.08. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 31% · Chronic kidney disease 24% · Coronary heart disease 23% · Atrial fibrillation 18% · Depression 16% · Cancer 15% · Heart failure 13% · COPD 10% · Stroke 8% · Dementia 7%.
The office billed $620,705, Medicare allowed $204,888 and paid $159,494; for 4,970 services of 37 kinds; $1,435 of it was for drugs given in the office and $158,059 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,503 | 4,970 | 76 | 1.08 | $620,705 | $159,494 |
| 2023 | 1,473 | 4,587 | 76 | 1.09 | $523,226 | $140,874 |
| 2022 | 1,416 | 4,244 | 76 | 1.05 | $411,428 | $100,719 |
| 2021 | 1,162 | 3,105 | 76 | 1.09 | $357,112 | $95,042 |
| 2020 | 196 | 1,217 | 77 | 1.70 | $320,872 | $80,142 |
| 2019 | 200 | 979 | 77 | 1.69 | $283,902 | $68,973 |
| 2018 | 215 | 1,464 | 77 | 1.88 | $385,639 | $97,870 |
| 2017 | 198 | 1,451 | 77 | 1.84 | $349,762 | $88,176 |
| 2016 | 204 | 1,968 | 76 | 1.95 | $374,357 | $98,694 |
| 2015 | 224 | 1,374 | 76 | 2.04 | $292,836 | $95,499 |
| 2014 | 230 | 1,470 | 75 | 1.82 | $277,959 | $92,197 |
| 2013 | 234 | 1,477 | 75 | 1.93 | $190,432 | $93,631 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Short return visit (20+ min) | 217 | $49,102 | $82 |
| Insertion of needle into vein for collection of blood sample | 1,318 | $25,680 | $8 |
| Removal of fingernails or toenails, 6 or more nails | 145 | $12,143 | $39 |
| New patient visit (30+ min) | 91 | $9,079 | $100 |
| Removal of noncancer thickened skin growth, 2-4 growths | 50 | $7,482 | $80 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $6,873 | $132 |
| Return visit (30+ min) | 37 | $5,604 | $122 |
| Removal of noncancer thickened skin growth, 1 growth | 47 | $3,870 | $66 |
| New patient visit (45+ min) | 22 | $3,105 | $141 |
| Short return visit | 35 | $2,264 | $57 |
| Permanent removal fingernail or toenail | 11 | $2,154 | $144 |
| Influenza vaccine split virus, preservative free | 13 | $935 | $72 |
| Removal of fingernails or toenails, 1-5 nails | 20 | $741 | $28 |
| Administration of influenza virus vaccine | 15 | $566 | $38 |
2022: 9 services
| Short return visit (20+ min) | 201 | $38,098 | $82 |
| Removal of fingernails or toenails, 6 or more nails | 137 | $10,216 | $39 |
| Insertion of needle into vein for collection of blood sample | 1,287 | $8,888 | $3 |
| New patient visit (30+ min) | 73 | $7,216 | $99 |
| New patient visit (45+ min) | 43 | $5,848 | $136 |
| Removal of noncancer thickened skin growth, 2-4 growths | 42 | $5,576 | $80 |
| Return visit (30+ min) | 33 | $4,162 | $116 |
| Removal of noncancer thickened skin growth, 1 growth | 30 | $2,860 | $62 |
| Removal of fingernails or toenails, 1-5 nails | 11 | $348 | $27 |
2021: 10 services
| Short return visit (20+ min) | 179 | $39,474 | $82 |
| Removal of fingernails or toenails, 6 or more nails | 123 | $11,227 | $40 |
| Return visit (30+ min) | 53 | $7,321 | $118 |
| Removal of noncancer thickened skin growth, 2-4 growths | 40 | $5,900 | $79 |
| Insertion of needle into vein for collection of blood sample | 1,023 | $5,705 | $3 |
| New patient visit (45+ min) | 34 | $5,229 | $154 |
| Strapping, unna boot | 13 | $4,766 | $68 |
| Removal of noncancer thickened skin growth, 1 growth | 33 | $3,691 | $70 |
| New patient visit (30+ min) | 34 | $3,329 | $98 |
| Removal of fingernails or toenails, 1-5 nails | 13 | $316 | $21 |
2020: 9 services
| Short return visit (20+ min) | 150 | $28,440 | $66 |
| Strapping, unna boot | 19 | $11,670 | $62 |
| Removal of fingernails or toenails, 6 or more nails | 119 | $10,570 | $39 |
| New patient visit (45+ min) | 36 | $5,537 | $154 |
| Return visit (30+ min) | 32 | $4,452 | $106 |
| Removal of noncancer thickened skin growth, 2-4 growths | 33 | $3,881 | $69 |
| Removal of noncancer thickened skin growth, 1 growth | 36 | $3,519 | $63 |
| New patient visit (30+ min) | 40 | $3,499 | $87 |
| Short return visit | 11 | $710 | $42 |
2019: 8 services
| Short return visit (20+ min) | 157 | $30,825 | $66 |
| Strapping, unna boot | 19 | $7,342 | $69 |
| Return visit (30+ min) | 51 | $6,496 | $97 |
| Removal of fingernails or toenails, 6 or more nails | 92 | $6,233 | $41 |
| New patient visit (45+ min) | 29 | $4,170 | $144 |
| New patient visit (30+ min) | 32 | $2,989 | $93 |
| Removal of noncancer thickened skin growth, 2-4 growths | 23 | $1,616 | $60 |
| Removal of noncancer thickened skin growth, 1 growth | 14 | $963 | $54 |
2018: 10 services
| Short return visit (20+ min) | 166 | $36,162 | $64 |
| Strapping, unna boot | 28 | $15,038 | $72 |
| Removal of fingernails or toenails, 6 or more nails | 123 | $11,187 | $41 |
| Return visit (30+ min) | 61 | $8,043 | $95 |
| New patient visit (45+ min) | 47 | $6,395 | $136 |
| Removal of noncancer thickened skin growth, 2-4 growths | 41 | $4,374 | $51 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $3,712 | $112 |
| Removal of noncancer thickened skin growth, 1 growth | 26 | $2,119 | $46 |
| New patient visit (30+ min) | 15 | $1,380 | $92 |
| Short return visit | 14 | $752 | $38 |
2017: 8 services
| Short return visit (20+ min) | 171 | $35,679 | $60 |
| Strapping, unna boot | 18 | $12,955 | $63 |
| Removal of fingernails or toenails, 6 or more nails | 124 | $11,728 | $38 |
| Return visit (30+ min) | 43 | $5,543 | $92 |
| New patient visit (45+ min) | 24 | $3,125 | $130 |
| Removal of noncancer thickened skin growth, 2-4 growths | 27 | $2,518 | $50 |
| Removal of noncancer thickened skin growth, 1 growth | 38 | $2,168 | $41 |
| New patient visit (30+ min) | 23 | $2,055 | $89 |
2016: 12 services
| Short return visit (20+ min) | 184 | $39,856 | $61 |
| Strapping, unna boot | 21 | $13,305 | $65 |
| Removal of fingernails or toenails, 6 or more nails | 132 | $12,585 | $39 |
| Return visit (30+ min) | 45 | $5,820 | $90 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $3,510 | $110 |
| Removal of noncancer thickened skin growth, 2-4 growths | 35 | $3,153 | $53 |
| Removal of noncancer thickened skin growth, 1 growth | 38 | $3,050 | $44 |
| New patient visit (45+ min) | 16 | $2,164 | $135 |
| New patient visit (30+ min) | 22 | $1,969 | $90 |
| Short return visit | 12 | $1,278 | $40 |
| Removal of fingernails or toenails, 1-5 nails | 13 | $394 | $28 |
| Tubular dressing with or without elastic, any width, per linear yard | 16 | $344 | $1 |
2015: 8 services
| Short return visit (20+ min) | 182 | $40,074 | $68 |
| Removal of fingernails or toenails, 6 or more nails | 136 | $14,423 | $44 |
| Strapping, unna boot | 24 | $7,551 | $69 |
| Return visit (30+ min) | 44 | $6,035 | $106 |
| New patient visit (30+ min) | 43 | $3,919 | $91 |
| New patient visit (45+ min) | 25 | $3,844 | $154 |
| Removal of noncancer thickened skin growth, 2-4 growths | 35 | $3,490 | $58 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $2,057 | $49 |
2014: 10 services
| Short return visit (20+ min) | 185 | $36,886 | $64 |
| Removal of fingernails or toenails, 6 or more nails | 141 | $13,599 | $41 |
| Strapping, unna boot | 13 | $9,394 | $68 |
| Return visit (30+ min) | 37 | $4,810 | $98 |
| Removal of noncancer thickened skin growth, 2-4 growths | 39 | $4,671 | $56 |
| New patient visit (30+ min) | 48 | $4,488 | $93 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $3,052 | $109 |
| New patient visit (45+ min) | 16 | $2,429 | $152 |
| Removal of noncancer thickened skin growth, 1 growth | 33 | $2,373 | $45 |
| Removal of fingernails or toenails, 1-5 nails | 11 | $375 | $29 |
2013: 11 services
| Short return visit (20+ min) | 188 | $32,912 | $65 |
| Removal of fingernails or toenails, 6 or more nails | 134 | $12,627 | $42 |
| Strapping, unna boot | 27 | $9,249 | $56 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $6,881 | $115 |
| New patient visit (30+ min) | 63 | $5,935 | $94 |
| Return visit (30+ min) | 38 | $4,581 | $95 |
| Removal of noncancer thickened skin growth, 2-4 growths | 43 | $3,856 | $55 |
| New patient visit (45+ min) | 23 | $3,448 | $150 |
| Removal of noncancer thickened skin growth, 1 growth | 44 | $2,708 | $46 |
| Removal of fingernails or toenails, 1-5 nails | 12 | $473 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $22 | None |
Drugs they prescribed that Part D paid
$5,779
Pharmacies billed $5,779 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 6% of their Part D prescriptions (29 of 454) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
454 generic and 0 brand-name prescriptions · $5,779 in drug cost · 142 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Itraconazole | 21 | $1,752 | $83 |
| Gabapentin | 127 | $1,338 | $11 |
| Doxycycline Hyclate | 116 | $751 | $6 |
| Diclofenac | 44 | $709 | $16 |
| Terbinafine | 19 | $154 | $8 |
See all 7 drugs
| Itraconazole | 21 | $1,752 | $83 |
| Gabapentin | 127 | $1,338 | $11 |
| Doxycycline Hyclate | 116 | $751 | $6 |
| Diclofenac | 44 | $709 | $16 |
| Terbinafine | 19 | $154 | $8 |
| Hydrocodone-Acetaminophen | 28 | $110 | $4 |
| Sulfamethoxazole-Trimethoprim | 11 | $25 | $2 |
Year by year
| 2024 | 454 | 161 | 6% (29) | 0% | $5,779 |
| 2023 | 397 | 144 | 7% (26) | 0% | $12,136 |
| 2022 | 346 | 117 | 6% (22) | None | $15,006 |
| 2021 | 346 | 116 | 6% (20) | None | $11,294 |
| 2020 | 223 | 80 | 5% (12) | None | $7,409 |
| 2019 | 247 | 80 | 5% (13) | 6% | $14,684 |
| 2018 | 219 | 87 | 5% (11) | 6% | $17,389 |
| 2017 | 213 | 75 | 9% (18) | 7% | $12,632 |
| 2016 | 226 | 86 | 12% (28) | 8% | $12,942 |
| 2015 | 196 | 79 | 9% (17) | 15% | $22,014 |
| 2014 | 159 | 77 | 10% (16) | 8% | $8,375 |
| 2013 | 244 | 89 | 12% (28) | 7% | $8,481 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Itraconazole | 16 | $4,727 | $295 |
| Doxycycline Hyclate | 108 | $2,207 | $20 |
| Gabapentin | 125 | $1,356 | $11 |
| Diclofenac | 31 | $643 | $21 |
| Ciclopirox | 12 | $641 | $53 |
| Terbinafine | 15 | $157 | $10 |
| Hydrocodone-Acetaminophen | 19 | $90 | $5 |
| Meloxicam | 11 | $15 | $1 |
2022: 6 drugs
| Itraconazole | 22 | $2,666 | $121 |
| Doxycycline Hyclate | 80 | $1,581 | $20 |
| Gabapentin | 112 | $1,504 | $13 |
| Diclofenac | 30 | $625 | $21 |
| Terbinafine | 15 | $285 | $19 |
| Hydrocodone-Acetaminophen | 21 | $79 | $4 |
2021: 8 drugs
| Itraconazole | 13 | $3,182 | $245 |
| Doxycycline Hyclate | 65 | $1,482 | $23 |
| Gabapentin | 130 | $910 | $7 |
| Diclofenac | 15 | $324 | $22 |
| Terbinafine | 16 | $171 | $11 |
| Hydrocodone-Acetaminophen | 15 | $65 | $4 |
| Sulfamethoxazole-Trimethoprim | 13 | $52 | $4 |
| Ibuprofen | 13 | $49 | $4 |
2020: 4 drugs
| Doxycycline Hyclate | 50 | $1,265 | $25 |
| Gabapentin | 84 | $845 | $10 |
| Pregabalin | 11 | $658 | $60 |
| Terbinafine | 33 | $267 | $8 |
2019: 5 drugs
| Lyrica | 13 | $5,992 | $461 |
| Doxycycline Hyclate | 76 | $1,906 | $25 |
| Gabapentin | 81 | $1,350 | $17 |
| Terbinafine | 24 | $304 | $13 |
| Hydrocodone-Acetaminophen | 13 | $70 | $5 |
2018: 4 drugs
| Lyrica | 14 | $7,644 | $546 |
| Doxycycline Hyclate | 89 | $2,488 | $28 |
| Gabapentin | 50 | $688 | $14 |
| Cephalexin | 13 | $217 | $17 |
2017: 5 drugs
| Lyrica | 12 | $4,835 | $403 |
| Doxycycline Hyclate | 89 | $1,707 | $19 |
| Gabapentin | 28 | $501 | $18 |
| Cephalexin | 19 | $331 | $17 |
| Hydrocodone-Acetaminophen | 14 | $61 | $4 |
2016: 6 drugs
| Lyrica | 12 | $4,205 | $350 |
| Doxycycline Hyclate | 74 | $2,563 | $35 |
| Gabapentin | 41 | $1,299 | $32 |
| Hydrocodone-Acetaminophen | 21 | $173 | $8 |
| Cephalexin | 13 | $159 | $12 |
| Terbinafine | 17 | $146 | $9 |
2015: 6 drugs
| Jublia | 13 | $12,403 | $954 |
| Lyrica | 11 | $3,407 | $310 |
| Doxycycline Hyclate | 52 | $2,367 | $46 |
| Gabapentin | 59 | $1,423 | $24 |
| Terbinafine | 14 | $137 | $10 |
| Hydrocodone-Acetaminophen | 15 | $85 | $6 |
2014: 4 drugs
| Lyrica | 12 | $3,063 | $255 |
| Doxycycline Hyclate | 45 | $2,958 | $66 |
| Gabapentin | 54 | $861 | $16 |
| Hydrocodone-Acetaminophen | 12 | $207 | $17 |
2013: 5 drugs
| Doxycycline Hyclate | 65 | $2,952 | $45 |
| Lyrica | 13 | $2,840 | $218 |
| Gabapentin | 79 | $1,003 | $13 |
| Cephalexin | 17 | $180 | $11 |
| Hydrocodone-Acetaminophen | 23 | $82 | $4 |
Money from drug and device companies
$80 in 2025
| 2025 | 1 | 3 | None | $80 |
| 2024 | 1 | 1 | None | $26 |
| 2023 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Ortholoc 2 Lapifuse | $80 | 3 payments
|
See all 3 published payments
| Stryker | Meals · 2025-10-01 | Fixos | $20 |
| Stryker | Meals · 2025-09-09 | Ortholoc 2 Lapifuse | $43 |
| Stryker | Meals · 2025-06-17 | Ortholoc 2 Lapifuse | $17 |
See earlier years (2024, 2023)
2024: $26
| Dexcom | Dexcom G6 Transmitter | $26 | 1 payment
|
2023: $23
| GlaxoSmithKline | Arexvy | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1730290032
- Licence
- CA E4304
- Trained
- California School of Podiatric Medicine, 1999
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 625 Lincoln Ave, San Jose, CA, 95126
- NPI first listed
- 2006-08-31
- NPI last updated
- 2020-12-04
- NPI record certified
- 2020-12-04
This is when the NPI record was last certified, not a medical board exam.